PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32420546-10 2020 Results: Oral treatment of D-galactose-injected rats with BDS, PDS, CDS, or ZH ameliorated the serum hepatic function parameters as well as serum levels of adiponectin, apolipoprotein B 100, and insulin. Galactose 27-38 adiponectin, C1Q and collagen domain containing Rattus norvegicus 156-167 32420546-10 2020 Results: Oral treatment of D-galactose-injected rats with BDS, PDS, CDS, or ZH ameliorated the serum hepatic function parameters as well as serum levels of adiponectin, apolipoprotein B 100, and insulin. Galactose 27-38 apolipoprotein B Rattus norvegicus 169-189 32420546-10 2020 Results: Oral treatment of D-galactose-injected rats with BDS, PDS, CDS, or ZH ameliorated the serum hepatic function parameters as well as serum levels of adiponectin, apolipoprotein B 100, and insulin. Cadmium 68-71 adiponectin, C1Q and collagen domain containing Rattus norvegicus 156-167 32420546-10 2020 Results: Oral treatment of D-galactose-injected rats with BDS, PDS, CDS, or ZH ameliorated the serum hepatic function parameters as well as serum levels of adiponectin, apolipoprotein B 100, and insulin. zh 76-78 adiponectin, C1Q and collagen domain containing Rattus norvegicus 156-167 32420546-10 2020 Results: Oral treatment of D-galactose-injected rats with BDS, PDS, CDS, or ZH ameliorated the serum hepatic function parameters as well as serum levels of adiponectin, apolipoprotein B 100, and insulin. zh 76-78 apolipoprotein B Rattus norvegicus 169-189